Maria Sullivan

Summary

Affiliation: Columbia University
Country: USA

Publications

  1. pmc Abuse liability of prescription opioids compared to heroin in morphine-maintained heroin abusers
    Sandra D Comer
    Division on Substance Abuse, New York State Psychiatric Institute, College of Physicians and Surgeons of Columbia University, New York, NY 10032, USA
    Neuropsychopharmacology 33:1179-91. 2008
  2. ncbi request reprint Predictors of retention in naltrexone maintenance for opioid dependence: analysis of a stage I trial
    Maria A Sullivan
    Department of Psychiatry, New York State Psychiatric Institute, New York, NY, USA
    Am J Addict 15:150-9. 2006
  3. ncbi request reprint Attention deficit/hyperactivity disorder and substance abuse. Diagnostic and therapeutic considerations
    M A Sullivan
    Department of Psychiatry, Columbia Presbyterian Medical Center, New York, NY 10032, USA
    Ann N Y Acad Sci 931:251-70. 2001
  4. ncbi request reprint Management of relapse in naltrexone maintenance for heroin dependence
    Maria A Sullivan
    College of Physicians and Surgeons of Columbia University, New York State Psychiatric Institute, 1051 Riverside Drive, New York, NY 10032, USA
    Drug Alcohol Depend 91:289-92. 2007
  5. doi request reprint Uses of coercion in addiction treatment: clinical aspects
    Maria A Sullivan
    Columbia College of Physicians and Surgeons New York State Psychiatric Institute, New York, NY 10032, USA
    Am J Addict 17:36-47. 2008
  6. ncbi request reprint Current perspectives on smoking cessation among substance abusers
    Maria A Sullivan
    Department of Psychiatry, College of Physicians and Surgeons, New York State Psychiatric Institute at Columbia University, NY 10032, USA
    Curr Psychiatry Rep 4:388-96. 2002
  7. pmc Comparison of substance use milestones in cannabis- and cocaine-dependent patients
    Jonathan T Horey
    Division on Substance Abuse, New York Psychiatric Institute, New York, New York 10022, USA
    J Addict Dis 31:60-6. 2012
  8. pmc Intermittent marijuana use is associated with improved retention in naltrexone treatment for opiate-dependence
    Wilfrid Noel Raby
    Division on Substance Abuse, Department of Psychiatry, Columbia University, New York State Psychiatric Institute, New York, NY 10032, USA
    Am J Addict 18:301-8. 2009
  9. pmc Comparison of clinical trial recruitment populations: treatment-seeking characteristics of opioid-, cocaine-, and cannabis-using participants
    John J Mariani
    Division on Substance Abuse, New York State Psychiatric Institute, New York, NY 10032, USA
    J Subst Abuse Treat 40:426-30. 2011
  10. pmc Abuse liability of oxycodone as a function of pain and drug use history
    S D Comer
    Department of Psychiatry, Columbia University and the New York State Psychiatric Institute, 1051 Riverside Drive, Unit 120, New York, NY 10032, USA
    Drug Alcohol Depend 109:130-8. 2010

Collaborators

Detail Information

Publications28

  1. pmc Abuse liability of prescription opioids compared to heroin in morphine-maintained heroin abusers
    Sandra D Comer
    Division on Substance Abuse, New York State Psychiatric Institute, College of Physicians and Surgeons of Columbia University, New York, NY 10032, USA
    Neuropsychopharmacology 33:1179-91. 2008
    ..The abuse liabilities of fentanyl, morphine, oxycodone, and heroin, however, appear to be similar under these experimental conditions...
  2. ncbi request reprint Predictors of retention in naltrexone maintenance for opioid dependence: analysis of a stage I trial
    Maria A Sullivan
    Department of Psychiatry, New York State Psychiatric Institute, New York, NY, USA
    Am J Addict 15:150-9. 2006
    ....
  3. ncbi request reprint Attention deficit/hyperactivity disorder and substance abuse. Diagnostic and therapeutic considerations
    M A Sullivan
    Department of Psychiatry, Columbia Presbyterian Medical Center, New York, NY 10032, USA
    Ann N Y Acad Sci 931:251-70. 2001
    ..We suggest promising areas of focus for clinical research trials targeting the subpopulation of substance abusers with concurrent ADHD...
  4. ncbi request reprint Management of relapse in naltrexone maintenance for heroin dependence
    Maria A Sullivan
    College of Physicians and Surgeons of Columbia University, New York State Psychiatric Institute, 1051 Riverside Drive, New York, NY 10032, USA
    Drug Alcohol Depend 91:289-92. 2007
    ..Time retained in treatment was examined as a function of whether lapses to opioid use occurred while adherent to naltrexone (blocked use), or after having missed naltrexone doses (unblocked)...
  5. doi request reprint Uses of coercion in addiction treatment: clinical aspects
    Maria A Sullivan
    Columbia College of Physicians and Surgeons New York State Psychiatric Institute, New York, NY 10032, USA
    Am J Addict 17:36-47. 2008
    ..The philosophical, historical, and societal aspects of coerced treatment are considered...
  6. ncbi request reprint Current perspectives on smoking cessation among substance abusers
    Maria A Sullivan
    Department of Psychiatry, College of Physicians and Surgeons, New York State Psychiatric Institute at Columbia University, NY 10032, USA
    Curr Psychiatry Rep 4:388-96. 2002
    ..Smoking cessation is indicated for substance dependent persons already in recovery and may protect against relapse to the illicit drug of abuse...
  7. pmc Comparison of substance use milestones in cannabis- and cocaine-dependent patients
    Jonathan T Horey
    Division on Substance Abuse, New York Psychiatric Institute, New York, New York 10022, USA
    J Addict Dis 31:60-6. 2012
    ..To compare the progression of substance use milestones between cocaine- and cannabis-dependent patients...
  8. pmc Intermittent marijuana use is associated with improved retention in naltrexone treatment for opiate-dependence
    Wilfrid Noel Raby
    Division on Substance Abuse, Department of Psychiatry, Columbia University, New York State Psychiatric Institute, New York, NY 10032, USA
    Am J Addict 18:301-8. 2009
    ..Experimental studies are needed to directly test the hypothesis that cannabinoid agonists exert a beneficial pharmacological effect on naltrexone maintenance and to understand the mechanism...
  9. pmc Comparison of clinical trial recruitment populations: treatment-seeking characteristics of opioid-, cocaine-, and cannabis-using participants
    John J Mariani
    Division on Substance Abuse, New York State Psychiatric Institute, New York, NY 10032, USA
    J Subst Abuse Treat 40:426-30. 2011
    ..These results have implications for clinical trial recruitment and public health efforts directed at encouraging cannabis-dependent individuals to seek treatment...
  10. pmc Abuse liability of oxycodone as a function of pain and drug use history
    S D Comer
    Department of Psychiatry, Columbia University and the New York State Psychiatric Institute, 1051 Riverside Drive, Unit 120, New York, NY 10032, USA
    Drug Alcohol Depend 109:130-8. 2010
    ..These data suggest that an assessment of the reinforcing effects of opioids may be a sensitive method for differentiating opioid abusers from non-abusers...
  11. ncbi request reprint Advances in non-nicotine pharmacotherapy for smoking cessation
    L S Covey
    New York State Psychiatric Institute, New York 10032, USA
    Drugs 59:17-31. 2000
    ..Thus, available evidence indicates that non-nicotine drug treatments offer a promising panoply of therapeutic strategies for the addicted smoker...
  12. ncbi request reprint Concurrent substance use and outcome in combined behavioral and naltrexone therapy for opiate dependence
    S H Church
    New York State Psychiatric Institute, Substance Treatment and Research Service, New York 10032, USA
    Am J Drug Alcohol Abuse 27:441-52. 2001
    ..Further research is needed to identify the optimal therapeutic stance toward other drug use during treatment for opiate dependence...
  13. ncbi request reprint Injectable, sustained-release naltrexone for the treatment of opioid dependence: a randomized, placebo-controlled trial
    Sandra D Comer
    Division on Substance Abuse, New York State Psychiatric Institute, and Department of Psychiatry, College of Physicians and Surgeons of Columbia University, New York 10032, USA
    Arch Gen Psychiatry 63:210-8. 2006
    ..Oral naltrexone can completely antagonize the effects produced by opioid agonists. However, poor compliance with naltrexone has been a major obstacle to the effective treatment of opioid dependence...
  14. ncbi request reprint Nicotine dependence: the role for antidepressants and anxiolytics
    Maria A Sullivan
    New York State Psychiatric Institute, New York 10032, USA
    Curr Opin Investig Drugs 3:262-71. 2002
    ..The norepinephrinergic effects of nicotine may account for increased attentiveness and improved performance in repetitive tasks, while its anxiolytic effects are likely mediated through GABA and the endorphins...
  15. ncbi request reprint Behavioral naltrexone therapy: an integrated treatment for opiate dependence
    Jami L Rothenberg
    The New York State Psychiatric Institute, Division on Substance Abuse, Substance Treatment and Research Service, 1051 Riverside Drive, New York, NY 10032, USA
    J Subst Abuse Treat 23:351-60. 2002
    ..Thus, attrition continues to be a serious problem for naltrexone maintenance, although further efforts to develop interventions such as BNT are warranted...
  16. pmc Response: providing relief, avoiding euphoria
    Dennis Paul
    Addict Sci Clin Pract 4:26-7. 2008
  17. doi request reprint Dextromethorphan and quinidine combination for heroin detoxification
    Evaristo Akerele
    Department of Psychiatry, Columbia University College of Physicians and Surgeons, New York, New York, USA
    Am J Addict 17:176-80. 2008
    ..Future studies should examine dextromethorphan as an adjunct to other anti-withdrawal medications and focus more on the relationship between dextrorphan levels and withdrawal suppression...
  18. ncbi request reprint Treatment of depression in patients with opiate dependence
    Edward V Nunes
    New York State Psychiatric Institute, and Department of Psychiatry, Columbia University College of Physicians and Surgeons, New York, New York 10032, USA
    Biol Psychiatry 56:793-802. 2004
    ..Research is needed on such integrated models of care and treatment algorithms to determine their efficacy and cost effectiveness...
  19. ncbi request reprint Sustained-release naltrexone: novel treatment for opioid dependence
    Sandra D Comer
    College of Physicians and Surgeons of Columbia University, New York State Psychiatric Institute, Department of Psychiatry, Unit 120, New York, NY 10032, USA
    Expert Opin Investig Drugs 16:1285-94. 2007
    ..The present paper describes the development of sustained-release naltrexone formulations and discusses the clinical issues associated with their use in treating opioid dependence...
  20. pmc Reducing hospital presentations for opioid overdose in patients treated with sustained release naltrexone implants
    Gary K Hulse
    School of Psychiatry and Clinical Neurosciences, University of Western Australia, QE II Medical Centre, Nedlands, WA 6009, Australia
    Drug Alcohol Depend 79:351-7. 2005
    ..A sub-group of this cohort (n=146; 83 males) had previously received treatment with oral naltrexone, which also allowed a comparison of overdoses pre- and post-oral and also post-implant treatments...
  21. ncbi request reprint Memantine produces modest reductions in heroin-induced subjective responses in human research volunteers
    Sandra D Comer
    Division on Substance Abuse, New York State Psychiatric Institute, 1051 Riverside Dr, Unit 120, New York, NY 10032, USA
    Psychopharmacology (Berl) 193:235-45. 2007
    ..Previous studies have demonstrated an interaction between opioids and noncompetitive antagonists at N-methyl-D: -aspartate (NMDA) receptors, but few studies have examined the utility of these medications for treating opioid dependence...
  22. ncbi request reprint Socially sanctioned coercion mechanisms for addiction treatment
    Edgar P Nace
    University of Texas, Southwestern Medical School, Dallas, TX, USA
    Am J Addict 16:15-23. 2007
    ..This unmet need, coupled with the evidence for positive clinical outcomes, highlights the call for implementing socially sanctioned mechanisms of coercion...
  23. ncbi request reprint Effects of alternative reinforcer and craving on the choice to smoke cigarettes in the laboratory
    Adam Bisaga
    Department of Psychiatry, Columbia University College of Physicians and Surgeons, New York, USA
    Hum Psychopharmacol 22:41-7. 2007
    ..This paradigm models the motivational component associated with choice to smoke and could be used to evaluate the effects of pharmacological and behavioral interventions to decrease cigarette smoking...
  24. ncbi request reprint Comparison of intravenous buprenorphine and methadone self-administration by recently detoxified heroin-dependent individuals
    Sandra D Comer
    The New York State Psychiatric Institute and College of Physicians and Surgeons of Columbia University, 1051 Riverside Dr, Unit 120, New York, NY 10032, USA
    J Pharmacol Exp Ther 315:1320-30. 2005
    ..These results demonstrate that under these experimental conditions, buprenorphine and methadone were equally effective in producing reinforcing and subjective effects...
  25. ncbi request reprint Depot naltrexone: antagonism of the reinforcing, subjective, and physiological effects of heroin
    Maria A Sullivan
    Division on Substance Abuse, New York State Psychiatric Institute and Department of Psychiatry, College of Physicians and Surgeons, Columbia University, 1051 Riverside Drive, Unit 120, New York, NY 10032, USA
    Psychopharmacology (Berl) 189:37-46. 2006
    ..Although it is highly effective in completely antagonizing the effects of opioids, medication noncompliance is a difficult obstacle to treatment. Therefore, a sustained-release form of naltrexone may improve treatment outcome...
  26. ncbi request reprint New-onset mania and psychosis following heroin detoxification and naltrexone maintenance
    Maria A Sullivan
    Am J Addict 14:486-7. 2005
  27. ncbi request reprint Behavioral therapy to augment oral naltrexone for opioid dependence: a ceiling on effectiveness?
    Edward V Nunes
    New York State Psychiatric Institute, Division on Substance Abuse, New York, New York 10032, USA
    Am J Drug Alcohol Abuse 32:503-17. 2006
    ..Future research should consider combinations of behavioral methods with new long-acting injectable or implantable naltrexone formulations...
  28. ncbi request reprint Sex differences and hormonal influences on response to cold pressor pain in humans
    William J Kowalczyk
    Division on Substance Abuse, New York State Psychiatric Institute, and Department of Psychiatry, College of Physicians and Surgeons, Columbia University, New York, New York 10032, USA
    J Pain 7:151-60. 2006
    ..These results suggest that circulating gonadal hormones might mediate adaptation to cold pressor pain...

Research Grants7

  1. Predictors of Relapse to Prescription Opioid Abuse Among Pain Patients
    Maria Sullivan; Fiscal Year: 2009
    ..These questions are of immediate clinical relevance to the treatment of chronic pain with opioid therapy. ..
  2. Predictors of Relapse to Prescription Opioid Abuse Among Pain Patients
    Maria Sullivan; Fiscal Year: 2007
    ..These questions are of immediate clinical relevance to the treatment of chronic pain with opioid therapy. ..
  3. Predictors of Relapse to Prescription Opioid Abuse Among Pain Patients
    Maria A Sullivan; Fiscal Year: 2010
    ..These questions are of immediate clinical relevance to the treatment of chronic pain with opioid therapy. ..